Prime Doctor RX Tirzepatide Review: The "Month" Is 28 Days (2026)

Prime Doctor RX charges $339 for compounded tirzepatide every four weeks, and prints that figure as a monthly one. There are thirteen four-week cycles in a year, not twelve, so a year of month-to-month treatment costs $4,407 rather than the $4,068 a monthly reading implies — one full extra charge a reader is never shown.¹ Read live on 13 September 2026.

The company's own arithmetic proves the cycle

This is not a guess about billing practice. Divide the prepaid totals by four-week cycles and every one of them lands exactly: $3,497 ÷ 13 = $269.00, which is the headline. $1,734 ÷ 6 = $289.00. $927 ÷ 3 = $309.00. On the semaglutide line, $2,327 ÷ 13 = $179.00 and $1,194 ÷ 6 = $199.00. Not one figure on the page divides cleanly by calendar months. The site says so in words too, twice: "Medication ships every four weeks" under every plan card, and, in the Terms, that services may bill "on a recurring billing cycle, including billing every 28 days".

Why a 28-day month matters more than it sounds

Thirteen charges instead of twelve is an 8.3% increase that never appears as a price change. At $339 a cycle it is an extra $339 a year against what a reader comparing "$339/mo" to a competitor's "$339/mo" believes they are comparing. Goldspan Health bills on the same four-week clock, and the pair of them are the reason our price index treats a four-week cycle as a different unit rather than a rounding difference.

The footnote it does honor

Give it this: the asterisk is not decoration. Every card carries the same line — "Starting price reflects the effective monthly cost when the 52-week option is paid upfront" — so the headline $269 announces its own commitment term instead of hiding it. That is more than Idgie Health, Edessa or RX Bella do with theirs, and the four-week cycle is disclosed in the same sentence rather than left to be discovered on a bank statement.

Who is behind it

The Terms of Service name no company, no LLC, no Inc and no address — the site publishes no operating entity anywhere. Governing law is Texas, the Terms took effect 5 February 2026 and were last updated 25 August 2026. Telehealth evaluation, clinical decision-making and prescribing are stated as provided by OpenLoop Health, so the clinical group is named even though the seller is not. The brand describes itself as veteran- and firefighter-owned.

The other costs on the page

The weight-loss ladder covers semaglutide injection ($249 every four weeks month-to-month), tirzepatide injection ($339) and oral semaglutide ($279). Testosterone starts "from $119/mo*" on the same asterisk. Hormone-care initial labs are $50, which is stated in a "how it works" step rather than anywhere in the pricing table.

The brand-vs-compounded question

This is compounded tirzepatide, not Zepbound or Mounjaro. Compounding happens at a pharmacy, produces no FDA-approved finished product, and puts the vial outside what the pivotal trials measured. Our guide to whether compounded tirzepatide is still legal in 2026 covers where that stands.

Does the drug work? (Separate from the provider)

Billing is the seller's problem; efficacy is the molecule's. SURMOUNT-1 put weight loss at roughly 15% to 21% of body weight over 72 weeks², and SURMOUNT-5 placed it ahead of semaglutide head to head³, both on the approved brand product. Our tirzepatide evidence guide has the full picture.

The honest verdict

The whole ladder is public before any intake, the asterisk tells the truth, and the clinical group is named — three things much of this field skips. Set against that: a 28-day cycle sold in "/mo" units, which costs you an extra charge every year, and a Terms of Service with no company in it. Work in cycles rather than months before you compare it to anything. If you want a month that is a month, Renlo Health bills monthly and says so on the price block; if you want the cycle and the pharmacy both named, No BS RX publishes four dispensing addresses. The ranked best tirzepatide providers list sets them against the field.